Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1771
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
Evil Rabbit
08/19/2025 12:43:30 PM
12 thumbs down. Thats impressive.
(10)
Evil Rabbit
08/19/2025 11:28:36 AM
Add the 30+ Ive deleted just this
(16)
waxonwaxoff
08/19/2025 11:23:26 AM
Have to agree. As much as I tried to
(10)
HHIGambler
08/19/2025 10:58:13 AM
My compassion ran out after I deleted
(11)
craigakess
08/19/2025 10:54:25 AM
The one thing I would say about Riz is
(9)
HHIGambler
08/19/2025 10:47:31 AM
He clearly has mental health issues. He
(11)
biloxiblues
08/19/2025 10:45:54 AM
Thank you to the Moderators. This
(8)
Evil Rabbit
08/19/2025 10:44:02 AM
Worst board member of all time and
(15)
HHIGambler
08/19/2025 10:40:22 AM
Can anyone with an ounce of sense
(11)
HHIGambler
08/19/2025 10:37:21 AM
You're reading 2-3 more words than me.
(11)
Evil Rabbit
08/19/2025 10:19:52 AM
MODS fingers must be blistered by
(13)
KenChowder
08/19/2025 7:23:45 AM
That's a good question, but we don't
(22)
My69z
08/19/2025 7:13:04 AM
Dec. 17th, 2024: If the RECOVER-TLC
(8)
MGK_2
08/19/2025 7:08:36 AM
I'd go along with that Ken, but tell me
(11)
KenChowder
08/19/2025 6:04:42 AM
MGK wrote: The two criteria that the
(25)
MGK_2
08/19/2025 5:05:16 AM
This is a more complete and concise
(11)
My69z
08/18/2025 9:59:11 PM
In progress: CRC 60 patient trial.
(11)
docj
08/18/2025 8:50:59 PM
I guess my initial reaction is... there
(11)
craigakess
08/18/2025 7:45:39 PM
Hey Riz. If I thought Leronlimab for
(10)
MGK_2
08/18/2025 7:23:36 PM
I provide this to give an idea of how
(28)
Buddyboy20
08/18/2025 6:54:00 PM
It seems like it was only a few days
(4)
waxonwaxoff
08/18/2025 3:16:52 PM
My first guess is either overly
(9)
HHIGambler
08/18/2025 2:50:49 PM
Sadly, he's reduced himself to being
(13)
waxonwaxoff
08/18/2025 2:36:12 PM
Amen. Thx to all the
(11)
sean007
08/18/2025 2:21:05 PM
YEP...it's a huge tell. Prank the
(12)
seemingly-harmless
08/18/2025 1:05:53 PM
25% in one week. somebody knows
(4)
Niele
08/18/2025 12:37:01 PM
Evil, Thanks for all you do. You, Wax
(16)
Evil Rabbit
08/18/2025 12:25:28 PM
Its our ex-mod turned pest. He must
(11)
hoops
08/18/2025 11:50:18 AM
Yup. I just got 6 thumbs down from user
(8)
hoops
08/18/2025 10:45:28 AM
We're starting to get some outlandish
(9)
My69z
08/18/2025 9:54:35 AM
So you going 2 play it safest by giving
(7)
generactor
08/17/2025 9:09:59 PM
I'm not invested in Cytodyn anymore so
(9)
sean007
08/17/2025 7:50:25 PM
Hoffman on deck,... and in the finance
(7)
sean007
08/17/2025 7:37:54 PM
For many,.. a Win is waking up in the
(7)
craigakess
08/17/2025 5:48:38 PM
100% agree with you. I just don't see
(6)
Cycl2R
08/17/2025 5:19:09 PM
>>That is the hope and why we are
(8)
sean007
08/17/2025 2:27:05 PM
Today represents the 90 day Notice of a
(11)
docj
08/17/2025 1:58:28 PM
When you are at the bottom of a
(6)
craigakess
08/17/2025 12:09:36 PM
Dosing a FIRST patient in OVER 2 YEARS
(15)
generactor
08/16/2025 10:09:40 PM
In June the company announced the first
(29)
Katangolo
08/16/2025 4:32:13 PM
Lipophylic characteristics of the
(6)
misiu143
08/16/2025 1:04:36 PM
Nice article , new evaluation. Thank
(5)
Plotinus
08/16/2025 12:24:29 PM
Related to the blood brain barrier,
(8)
hoops
08/16/2025 12:19:59 PM
Misiu, thank you for your contributions
(11)
misiu143
08/16/2025 11:39:12 AM
Crossing the BBB depend of many other
(18)
USS JOHNSTON
08/16/2025 10:05:07 AM
For Alzheimer's patients, there's a new
(8)
SamaGong
08/16/2025 8:40:34 AM
Interesting well done podcast. It's two
(3)
KenChowder
08/16/2025 2:53:31 AM
Great stuff! If Maraviroc can help,
(9)
misiu143
08/15/2025 6:40:05 PM
Very interesting for the patients , and
(11)
sean007
08/15/2025 2:51:11 PM
I will continue to Buy...up to
(5)
Newer
Older
Recent Articles
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy
Aalberts N.V. Strengthens Position with GVT Acquisition
Nxera Pharma's Innovations and Financial Report for 2025
Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
Vistin Pharma Reports Strong Q3 Results and Market Growth
Corbus Pharmaceuticals Sets Price for New Stock Offering
Introducing a New Executive Team Member at Realkredit Danmark
Aalberts Enhances Market Position Through Latest Acquisition
Exploring the Future of Green Hydrogen Development
Aker Solutions ASA Sees Revenue Boost in Third Quarter
Aker Solutions Reports Strong Performance in Q3 2025
Aker Solutions’ Record Growth and Promising Future Outlook
Investigation Launched into Conduent's Major Data Breach Event
Vallourec Secures Groundbreaking Contract for Deepwater Project
Essential Patient Inquiries for Portable X-Ray Scheduling
Exploring Affordable Coastal Living Alternatives Near Beaches
Intensity Therapeutics Sees Dip After Surging to New Heights
Marimekko's Strategic Growth and Operations in 2025
SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
SPIE Reports Robust Growth and Strategic Acquisitions in 2025
Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled
Marimekko Sees Growth in Q3 Revenue and Profits for 2025
Syensqo's Strategic Shift: Selling Oil & Gas Division to SNF
Elis Expands its Reach in Germany with New Acquisition Deal
Biotalys' EVOCA Biofungicide Nears EPA Approval, Changing Crop Protection
Hyundai and NVIDIA Unite for Advanced AI Innovation
Transforming Manufacturing: NVIDIA and SK Group's AI Collaboration
NVIDIA and Samsung Launch Revolutionary AI Manufacturing Factory
NVIDIA and South Korea Join Forces to Revolutionize AI Landscape
Vallourec Secures Major Offshore Contract with TechnipFMC
SCOR Achieves Remarkable Q3 2025 with Strong Net Income
Realsee Partners with Linkhome to Transform Real Estate with AI
Revolutionizing Retirement: How Physicians Are Investing Wisely